The Activities of Paraoxonase, Xanthine Oxidase, Adenosine Deaminase and the Level of Nitrite in Pseudoexfoliation Syndrome

被引:15
作者
Yagci, Ramazan [1 ]
Gurel, Ahmet [3 ]
Ersoz, Ibrahim [2 ]
Karadag, Remzi [1 ]
Hepsen, Ibrahim F. [1 ]
Duman, Sunay [2 ]
机构
[1] Fatih Univ, Sch Med, Dept Ophthalmol, Istanbul, Turkey
[2] Ankara Numune Training & Res Hosp, Dept Ophthalmol, Ankara, Turkey
[3] Karaelmas Univ, Dept Biochem & Clin Biochem, Sch Med, Zonguldak, Turkey
关键词
Paraoxonase; Xanthine oxidase; Adenosine deaminase; Nitric oxide; Pseudoexfoliation; ASCORBIC-ACID CONCENTRATION; OXIDATIVE STRESS; MALONDIALDEHYDE LEVELS; MACULAR DEGENERATION; EXFOLIATION SYNDROME; SUPEROXIDE-DISMUTASE; LIPID-PEROXIDATION; BEHCETS-DISEASE; AQUEOUS-HUMOR; SERUM;
D O I
10.1159/000229306
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Aim: Our purpose was to investigate the possible roles of nitrite levels and the activity of paraoxonase (PON), xanthine oxidase (XO) and adenosine deaminase (ADA) in the pathogenesis of pseudoexfoliation (PEX) syndrome. Methods: Serum samples were taken from 43 patients with PEX and 41 control subjects. The serum PON, XO and ADA activities and nitrite levels were assayed by spectrophotometric methods. Results: The PON, ADA and XO activities and nitrite levels (means +/- standard deviation) were 81.72 +/- 42.56 U/ml, 19.75 +/- 5.72 U/l, 0.16 +/- 0.09 U/l and 94.23 +/- 27.72 mu mol/l in the PEX group, respectively. In the control group, the PON, ADA and XO activities and the nitrite levels were 111.02 +/- 43.51 U/ml, 15.21 +/- 3.93 U/l, 0.13 +/- 0.06 U/l and 61.96 +/- 19.05 mu mol/l, respectively. The serum PON activity was significantly lower in the PEX group when compared with the control group. The serum XO and ADA activities and nitrite levels were significantly higher in the patients with PEX when compared with the control subjects. Conclusion: Decreased PON (an antioxidant enzyme) activity as well as increased ADA and XO activities and nitrite levels indicate that oxidative stress is increased and purine metabolism is altered in PEX syndrome. Copyright (C) 2009 S. Karger AG, Basel
引用
收藏
页码:155 / 159
页数:5
相关论文
共 40 条
  • [1] OXIDATIVE DAMAGE TO DNA - RELATION TO SPECIES METABOLIC-RATE AND LIFE-SPAN
    ADELMAN, R
    SAUL, RL
    AMES, BN
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (08) : 2706 - 2708
  • [2] Homocysteine and nitric oxide levels in plasma of patients with pseudoexfoliation syndrome, pseudoexfoliation glaucoma, and primary open-angle glaucoma
    Altintas, Ö
    Maral, H
    Yüksel, N
    Karabas, VL
    Dillioglugil, MÖ
    Çaglar, Y
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2005, 243 (07) : 677 - 683
  • [3] Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants
    Aviram, M
    Rosenblat, M
    Billecke, S
    Erogul, J
    Sorenson, R
    Bisgaier, CL
    Newton, RS
    La Du, B
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 1999, 26 (7-8) : 892 - 904
  • [4] Serum paraoxonase 1 activity and lipid peroxidation levels in patients with age-related macular degeneration
    Baskol, G
    Karakucuk, S
    Oner, AO
    Baskol, M
    Kocer, D
    Mirza, E
    Saraymen, R
    Üstdal, M
    [J]. OPHTHALMOLOGICA, 2006, 220 (01) : 12 - 16
  • [5] Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis
    Baskol, G
    Demir, H
    Baskol, M
    Kilic, E
    Ates, F
    Kocer, D
    Muhtaroglu, S
    [J]. CLINICAL BIOCHEMISTRY, 2005, 38 (10) : 951 - 955
  • [6] Serum paraoxonase 1 activity and malondialdehyde levels in patients with ulcerative colitis
    Baskol, Gulden
    Baskol, Mevlut
    Yurci, Alper
    Ozbakir, Omer
    Yucesoy, Mehmet
    [J]. CELL BIOCHEMISTRY AND FUNCTION, 2006, 24 (03) : 283 - 286
  • [7] The role of oxidative stress in the pathogenesis of age-related macular degeneration
    Beatty, S
    Koh, HH
    Henson, D
    Boulton, M
    [J]. SURVEY OF OPHTHALMOLOGY, 2000, 45 (02) : 115 - 134
  • [8] BRUNS RF, 1990, ANN NY ACAD SCI, V603, P211
  • [9] CORTAS NK, 1990, CLIN CHEM, V36, P1440
  • [10] Cristalli G, 2001, MED RES REV, V21, P105, DOI 10.1002/1098-1128(200103)21:2<105::AID-MED1002>3.0.CO